Learn More
Medchemexpress LLC N-[3-oxo-3-(4-pyridin-4-ylpiperazin-1-yl)propyl]-2,1,3-benzothiadiazole-4-sulfonamide | 1135243-19-4 | MFCD18086889 | 99.8% | 432.52 g·mol⁻¹ | C18H20N6O3S2 | 50 MG

Supplier: Medchemexpress LLC HY10823450MG
VU 0255035 is a selective, brain-penetrant muscarinic M1 receptor antagonist used as a research tool in neuroscience and pharmacology. It acts as a competitive M1 antagonist with demonstrated in vitro and in vivo activity, including reduction of cholinergic-induced neuronal depolarization and efficacy in seizure models. The compound is supplied as a well-characterized, high-purity small molecule for laboratory use.
- Selective muscarinic M1 receptor antagonist
- Brain-penetrant small molecule suitable for in vivo studies
- Demonstrated activity in electrophysiology and seizure models
- High purity suitable for pharmacology experiments
- Available in multiple laboratory-friendly package sizes
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.